LifeVantage Statistics
Total Valuation
LifeVantage has a market cap or net worth of $162.89 million. The enterprise value is $148.63 million.
| Market Cap | 162.89M |
| Enterprise Value | 148.63M |
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | May 30, 2025 |
Share Statistics
LifeVantage has 12.59 million shares outstanding. The number of shares has increased by 0.46% in one year.
| Current Share Class | 12.59M |
| Shares Outstanding | 12.59M |
| Shares Change (YoY) | +0.46% |
| Shares Change (QoQ) | +0.93% |
| Owned by Insiders (%) | 19.14% |
| Owned by Institutions (%) | 35.79% |
| Float | 8.57M |
Valuation Ratios
The trailing PE ratio is 18.47 and the forward PE ratio is 11.80.
| PE Ratio | 18.47 |
| Forward PE | 11.80 |
| PS Ratio | 0.69 |
| Forward PS | 0.60 |
| PB Ratio | 4.66 |
| P/TBV Ratio | 4.70 |
| P/FCF Ratio | 13.25 |
| P/OCF Ratio | 11.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.19, with an EV/FCF ratio of 12.41.
| EV / Earnings | 16.24 |
| EV / Sales | 0.67 |
| EV / EBITDA | 9.19 |
| EV / EBIT | 11.47 |
| EV / FCF | 12.41 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.66 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 0.68 |
| Debt / FCF | 1.03 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 30.11% and return on invested capital (ROIC) is 18.69%.
| Return on Equity (ROE) | 30.11% |
| Return on Assets (ROA) | 11.69% |
| Return on Invested Capital (ROIC) | 18.69% |
| Return on Capital Employed (ROCE) | 29.03% |
| Revenue Per Employee | $1.00M |
| Profits Per Employee | $41,221 |
| Employee Count | 222 |
| Asset Turnover | 3.21 |
| Inventory Turnover | 2.34 |
Taxes
In the past 12 months, LifeVantage has paid $3.41 million in taxes.
| Income Tax | 3.41M |
| Effective Tax Rate | 27.13% |
Stock Price Statistics
The stock price has increased by +74.94% in the last 52 weeks. The beta is 0.44, so LifeVantage's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +74.94% |
| 50-Day Moving Average | 13.99 |
| 200-Day Moving Average | 14.27 |
| Relative Strength Index (RSI) | 46.72 |
| Average Volume (20 Days) | 219,370 |
Short Selling Information
The latest short interest is 2.04 million, so 16.18% of the outstanding shares have been sold short.
| Short Interest | 2.04M |
| Short Previous Month | 1.74M |
| Short % of Shares Out | 16.18% |
| Short % of Float | 23.78% |
| Short Ratio (days to cover) | 11.93 |
Income Statement
In the last 12 months, LifeVantage had revenue of $222.35 million and earned $9.15 million in profits. Earnings per share was $0.70.
| Revenue | 222.35M |
| Gross Profit | 178.53M |
| Operating Income | 12.96M |
| Pretax Income | 4.19M |
| Net Income | 9.15M |
| EBITDA | 16.17M |
| EBIT | 12.96M |
| Earnings Per Share (EPS) | $0.70 |
Balance Sheet
The company has $22.47 million in cash and $12.36 million in debt, giving a net cash position of $10.11 million or $0.80 per share.
| Cash & Cash Equivalents | 22.47M |
| Total Debt | 12.36M |
| Net Cash | 10.11M |
| Net Cash Per Share | $0.80 |
| Equity (Book Value) | 34.01M |
| Book Value Per Share | 2.70 |
| Working Capital | 21.53M |
Cash Flow
In the last 12 months, operating cash flow was $13.43 million and capital expenditures -$1.45 million, giving a free cash flow of $11.98 million.
| Operating Cash Flow | 13.43M |
| Capital Expenditures | -1.45M |
| Free Cash Flow | 11.98M |
| FCF Per Share | $0.95 |
Margins
Gross margin is 80.29%, with operating and profit margins of 5.83% and 4.12%.
| Gross Margin | 80.29% |
| Operating Margin | 5.83% |
| Pretax Margin | 5.65% |
| Profit Margin | 4.12% |
| EBITDA Margin | 7.27% |
| EBIT Margin | 5.83% |
| FCF Margin | 5.39% |
Dividends & Yields
This stock pays an annual dividend of $0.18, which amounts to a dividend yield of 1.39%.
| Dividend Per Share | $0.18 |
| Dividend Yield | 1.39% |
| Dividend Growth (YoY) | -69.72% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 25.69% |
| Buyback Yield | -0.46% |
| Shareholder Yield | 0.97% |
| Earnings Yield | 5.76% |
| FCF Yield | 7.54% |
Analyst Forecast
The average price target for LifeVantage is $30.50, which is 135.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.50 |
| Price Target Difference | 135.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 19, 2015. It was a reverse split with a ratio of 0.1428571:1.
| Last Split Date | Oct 19, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.1428571:1 |
Scores
LifeVantage has an Altman Z-Score of 3.97 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.97 |
| Piotroski F-Score | 6 |